Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Preventing and treating amyloid-beta deposition by stimulation of innate immunity

Preventing and treating amyloid-beta deposition by stimulation of innate immunity

US Patent 10383887 · Granted Aug 20, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2022
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2021
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2021
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2021
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2021
Specific murine and humanized monoclonal antibodies detecting pathology associat2020
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal 2020
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2019
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2018
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2017
Method for treating amyloid disease2017
Mucosal immunization to prevent prion infection2017